{"id":809029,"date":"2025-02-05T07:35:27","date_gmt":"2025-02-05T12:35:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/"},"modified":"2025-02-05T07:35:27","modified_gmt":"2025-02-05T12:35:27","slug":"carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/","title":{"rendered":"Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n
\n PHILADELPHIA<\/span>
\n <\/span>, Feb. 5, 2025<\/span><\/span> \/PRNewswire\/ — Carisma Therapeutics Inc.<\/a> (Nasdaq: CARM<\/a>) (“Carisma” or the “Company”), a leader in macrophage-focused therapeutics, today announced that Steven Kelly<\/span>, President and Chief Executive Officer, will participate in the Oppenheimer 35th<\/sup> Annual Healthcare Life Sciences Conference on Tuesday, February 11<\/span> at 4:40 pm ET<\/span>.<\/p>\n

\n

\n
\n \"(PRNewsfoto\/CARISMA
\n <\/a>\n <\/p>\n<\/p><\/div>\n

An audio webcast of the event will be available on the Company’s\u00a0Investor Events<\/a>\u00a0section of the Investor Relations webpage and will be archived for a limited time following the event.<\/p>\n

\n About\u00a0Carisma <\/b>\n <\/p>\n

Carisma Therapeutics is a biopharmaceutical Company pioneering macrophage engineering to develop groundbreaking therapies for fibrosis, cancer, and other diseases. With a strong commitment to patient-centric innovation, Carisma aims to deliver scalable, next-generation solutions that transform treatment paradigms. Carisma is headquartered in\u00a0Philadelphia, PA.\u00a0For more information, please visit\u00a0www.Carismatx.com<\/a>.<\/p>\n

\n Investors:
<\/b>
\n Shveta Dighe<\/span>
\n
\n investors@carismatx.com<\/a>\n <\/p>\n

\n Media Contact:
<\/b>
\n Julia Stern<\/span>
\n
(763) 350-5223
jstern@realchemistry.com<\/a><\/p>\n

\n \"Cision\" View original content to download multimedia:https:\/\/www.prnewswire.com\/news-releases\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference-302367990.html<\/a><\/p>\n

SOURCE Carisma Therapeutics Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire PHILADELPHIA , Feb. 5, 2025 \/PRNewswire\/ — Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a leader in macrophage-focused therapeutics, today announced that Steven Kelly, President and Chief Executive Officer, will participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11 at 4:40 pm ET. An audio webcast of the event will be available on the Company’s\u00a0Investor Events\u00a0section of the Investor Relations webpage and will be archived for a limited time following the event. About\u00a0Carisma Carisma Therapeutics is a biopharmaceutical Company pioneering macrophage engineering to develop groundbreaking therapies for fibrosis, cancer, and other diseases. With a strong commitment to patient-centric innovation, Carisma aims to deliver scalable, next-generation solutions that transform treatment paradigms. Carisma … <\/p>\n

Continue reading “Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-809029","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCarisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire PHILADELPHIA , Feb. 5, 2025 \/PRNewswire\/ — Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a leader in macrophage-focused therapeutics, today announced that Steven Kelly, President and Chief Executive Officer, will participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11 at 4:40 pm ET. An audio webcast of the event will be available on the Company’s\u00a0Investor Events\u00a0section of the Investor Relations webpage and will be archived for a limited time following the event. About\u00a0Carisma Carisma Therapeutics is a biopharmaceutical Company pioneering macrophage engineering to develop groundbreaking therapies for fibrosis, cancer, and other diseases. With a strong commitment to patient-centric innovation, Carisma aims to deliver scalable, next-generation solutions that transform treatment paradigms. Carisma … Continue reading "Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-05T12:35:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1219543\/Carisma_Therapeutics_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference\",\"datePublished\":\"2025-02-05T12:35:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/\"},\"wordCount\":175,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1219543\\\/Carisma_Therapeutics_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/\",\"name\":\"Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1219543\\\/Carisma_Therapeutics_Logo.jpg\",\"datePublished\":\"2025-02-05T12:35:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1219543\\\/Carisma_Therapeutics_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1219543\\\/Carisma_Therapeutics_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/","og_locale":"en_US","og_type":"article","og_title":"Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference - Market Newsdesk","og_description":"PR Newswire PHILADELPHIA , Feb. 5, 2025 \/PRNewswire\/ — Carisma Therapeutics Inc. (Nasdaq: CARM) (“Carisma” or the “Company”), a leader in macrophage-focused therapeutics, today announced that Steven Kelly, President and Chief Executive Officer, will participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11 at 4:40 pm ET. An audio webcast of the event will be available on the Company’s\u00a0Investor Events\u00a0section of the Investor Relations webpage and will be archived for a limited time following the event. About\u00a0Carisma Carisma Therapeutics is a biopharmaceutical Company pioneering macrophage engineering to develop groundbreaking therapies for fibrosis, cancer, and other diseases. With a strong commitment to patient-centric innovation, Carisma aims to deliver scalable, next-generation solutions that transform treatment paradigms. Carisma … Continue reading \"Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-05T12:35:27+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1219543\/Carisma_Therapeutics_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference","datePublished":"2025-02-05T12:35:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/"},"wordCount":175,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1219543\/Carisma_Therapeutics_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/","name":"Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1219543\/Carisma_Therapeutics_Logo.jpg","datePublished":"2025-02-05T12:35:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1219543\/Carisma_Therapeutics_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1219543\/Carisma_Therapeutics_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/carisma-therapeutics-to-participate-in-oppenheimer-35th-annual-healthcare-life-sciences-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/809029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=809029"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/809029\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=809029"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=809029"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=809029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}